The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 16, 2021

Filed:

Nov. 06, 2017
Applicant:

Idorsia Pharmaceuticals Ltd, Allschwil, CH;

Inventors:

Marc Bellet, Allschwil, CH;

Martin Bolli, Allschwil, CH;

Martine Clozel, Allschwil, CH;

Marc Iglarz, Allschwil, CH;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); A61P 9/12 (2006.01); A61K 31/4035 (2006.01); A61K 31/41 (2006.01); A61K 31/4418 (2006.01); A61K 31/506 (2006.01); A61K 31/549 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 31/4035 (2013.01); A61K 31/41 (2013.01); A61K 31/4418 (2013.01); A61K 31/506 (2013.01); A61K 31/549 (2013.01); A61P 9/12 (2018.01); C07B 2200/13 (2013.01);
Abstract

The present invention concerns the compound aprocitentan, {5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-sulfamide, and its use as endothelin receptor antagonist, in combination with other active ingredients or therapeutic agents including an angiotenin receptor blocker, and/or a calcium channel blocker, and preferably a diuretic which is a thiazide-like diuretic, in the prophylaxis or treatment of certain endothelin related diseases. The invention further relates to pharmaceutical compositions comprising aprocitentan in combination with said other active ingredients or therapeutic agents. The invention further relates to such pharmaceutical compositions comprising novel crystalline forms of aprocitentan.


Find Patent Forward Citations

Loading…